These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 216602)

  • 1. [Dyslipidemia and accelerated atherosclerosis in chronic uremia: a probably decreasing pathology, due to nutritional studies and better dietary guidelines].
    Campanacci L; Guabnieri GF; Toigo G; Huber W; Legnani F; Moracchiello M; Tesio F; Raimondi A
    G Clin Med; 1978; 59(7-8):318-31. PubMed ID: 216602
    [No Abstract]   [Full Text] [Related]  

  • 2. Atherosclerosis in patients undergoing maintenance hemodialysis.
    Bagdade JD
    Kidney Int Suppl; 1975 Feb; (3):370-2. PubMed ID: 169427
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis.
    Cattran DC; Steiner G; Fenton SS; Wilson DR
    Trans Am Soc Artif Intern Organs; 1974; 20A():148-52. PubMed ID: 4450333
    [No Abstract]   [Full Text] [Related]  

  • 4. Longitudinal study on hyperlipidaemia and diet in RDT patients.
    Palmo A; Boggio-Bertinet D; Balzola F; Stratta P; Triolo G; Alloatti S; Bosticardo G; Giacchino F; Pagano GF; Levis F
    Minerva Nefrol; 1982; 29(1):29-35. PubMed ID: 7048140
    [No Abstract]   [Full Text] [Related]  

  • 5. Atherosclerosis in uremia: a longitudinal study.
    Bonomini V; Feletti C; Scolari MP; Stefoni S; Vangelista A
    Am J Clin Nutr; 1980 Jul; 33(7):1493-500. PubMed ID: 6994473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dyslipidemia in renal failure].
    Fujioka T; Ueno T; Matsumoto T; Watanabe H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():118-23. PubMed ID: 15250280
    [No Abstract]   [Full Text] [Related]  

  • 7. Should hyperlipemia of renal failure be treated?
    Ritz E; Augustin J; Bommer J; Gnasso A; Haberbosch W
    Kidney Int Suppl; 1985 Dec; 17():S84-7. PubMed ID: 3867805
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful reduction of hypertriglyceridaemia (H.T.G.) by ambulatory dietary manipulation in young dialysed patients.
    Ciancioni C; Dairou F; Delons S; Naret C; de Gennes JL; Jungers P
    Proc Eur Dial Transplant Assoc; 1978; 15():601-3. PubMed ID: 216991
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid metabolism in hemofiltration. Comparison with the lipid pattern of hemodialyzed patients].
    Civati G; Galato R; Franceschini G; Guastoni C; Perego A; Minetti L
    Minerva Nefrol; 1980; 27(4):669-74. PubMed ID: 7254694
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics of clofibrate in uremic patients treated with dialysis. Effects of dietetic and drug therapy on triglycerides in the blood].
    Garini G; Vaona GL; Arisi L; Bignardi L; David S; Gaudiano V; Rossi E; Savazzi GM; Cambi V; Migone L
    Minerva Nefrol; 1979; 26(1):55-60. PubMed ID: 471323
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary trials of dialysis with a bath fluid of low acetate content. Relation to triglycerides].
    Bandiani G; Camaiora E; Nicolini MA; Perotta U
    Minerva Nefrol; 1979; 26(1):75-7. PubMed ID: 471327
    [No Abstract]   [Full Text] [Related]  

  • 12. Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation.
    Nishizawa Y; Shoji T; Kawagishi T; Morii H
    Kidney Int Suppl; 1997 Nov; 62():S90-2. PubMed ID: 9350691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorders of carbohydrate and lipid metabolism in uremia.
    Bagdade
    Nephron; 1975; 14(2):153-62. PubMed ID: 1093054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of glucose-free dialysate on blood lipid concentration in chronic intermittent hemodialysis].
    Ravens KG; Callesen D
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1273-4. PubMed ID: 206047
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid metabolism in uremia and the effects of dialysate glucose and oral androgen therapy.
    Dombeck DH; Lindholm DD; Vieira JA
    Trans Am Soc Artif Intern Organs; 1973; 19():150-3. PubMed ID: 4352987
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism(s) of hyperlipidemia in chronic uremia.
    Bagdade JD; Shafrir E; Wilson DE
    Trans Am Soc Artif Intern Organs; 1976; 22():42-5. PubMed ID: 181888
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipids and lipoproteins in chronic uraemia. A study of the influence of regular haemodialysis.
    Daubresse JC; Lerson G; Plamteux G; Rorive G; Luyckx AS; Lefebvre PJ
    Eur J Clin Invest; 1976 Mar; 6(2):159-66. PubMed ID: 177295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].
    László A; Csalánosiné Németh M; Joó I; Kiss E; Havass Z; Szenohradszki P
    Orv Hetil; 1986 May; 127(19):1129-31. PubMed ID: 3714258
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of hypolipidemic drugs on serum lipoproteins.
    Carlson LA; Olsson AG
    Prog Biochem Pharmacol; 1979; 15():238-57. PubMed ID: 224397
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atherosclerosis and hypertriglyceremia in chronic renal failure].
    Lutz W
    Pol Tyg Lek; 1976 Jun; 31(25):1089-91. PubMed ID: 181736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.